Phase 1/2 Study of HS-10370 in Patients with Advanced Solid Tumors

Clinical trial NCT05367778 · RECRUITING

Trial details

NCT number: NCT05367778
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2022-06-03
Primary completion: 2025-04-30
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.